Peptide Library

In clinical trials

Digestive & weight

Mazdutide

Evidence

Clinical trials

Class

Dual GLP-1 and glucagon receptor agonist

/

Mazdutide

KEY TAKEAWAY

Mazdutide is a peptide that activates both the GLP-1 and glucagon receptors. Innovent Biologics developed it together with Eli Lilly. Mazdutide is not FDA-approved. It has been approved in China for weight management and is in clinical trials elsewhere.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Dual GLP-1 and glucagon receptor agonist

Being studied for

Studied for obesity, type 2 diabetes and fatty liver disease

Key fact

Mazdutide is not FDA-approved. It has been approved in China for weight management and is in clinical trials elsewhere.

Route

Weekly subcutaneous injection

Evidence strength

Clinical trials

What it is

What it is

Mazdutide is a peptide that activates both the GLP-1 and glucagon receptors. Innovent Biologics developed it together with Eli Lilly.

How it works

How it works

GLP-1 activity reduces appetite and improves blood sugar control. Glucagon activity may raise energy use and reduce fat in the liver.

Regulatory status

Regulatory status

Mazdutide is not FDA-approved. It has been approved in China for weight management and is in clinical trials elsewhere.

What it is used for

What it is used for

Studied for obesity, type 2 diabetes and fatty liver disease.

Side effects and risks

Side effects and risks

Nausea, vomiting and diarrhea were the most common effects in trials.

Citations

Citations

Mazdutide: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo